{"pmid":32273181,"title":"COVID-19 in a Kidney Transplant Patient.","text":["COVID-19 in a Kidney Transplant Patient.","Eur Urol","Wang, Junpeng","Li, Xin","Cao, Guanghui","Wu, Xiaoqiang","Wang, Zhiwei","Yan, Tianzhong","32273181"],"journal":"Eur Urol","authors":["Wang, Junpeng","Li, Xin","Cao, Guanghui","Wu, Xiaoqiang","Wang, Zhiwei","Yan, Tianzhong"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273181","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.eururo.2020.03.036","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663712077896744960,"score":7.9164424,"similar":[{"pmid":32233067,"title":"COVID-19 in Kidney Transplant Recipients.","text":["COVID-19 in Kidney Transplant Recipients.","An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly and has already taken on pandemic proportions. After China, Italy is the country with the highest number of cases so far (41,035 confirmed cases according to Dipartimento della Protezione Civile as of March 19, and 3,405 deaths). In Northern Italy, where the current prevalence of confirmed cases has surpassed in some areas 2 per 1,000 people, kidney transplant patients are getting infected and starting to develop coronavirus disease 2019 (COVID-19).","Am J Transplant","Gandolfini, Ilaria","Delsante, Marco","Fiaccadori, Enrico","Zaza, Gianluigi","Manenti, Lucio","Degli Antoni, Anna","Peruzzi, Licia","Riella, Leonardo V","Cravedi, Paolo","Maggiore, Umberto","32233067"],"abstract":["An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly and has already taken on pandemic proportions. After China, Italy is the country with the highest number of cases so far (41,035 confirmed cases according to Dipartimento della Protezione Civile as of March 19, and 3,405 deaths). In Northern Italy, where the current prevalence of confirmed cases has surpassed in some areas 2 per 1,000 people, kidney transplant patients are getting infected and starting to develop coronavirus disease 2019 (COVID-19)."],"journal":"Am J Transplant","authors":["Gandolfini, Ilaria","Delsante, Marco","Fiaccadori, Enrico","Zaza, Gianluigi","Manenti, Lucio","Degli Antoni, Anna","Peruzzi, Licia","Riella, Leonardo V","Cravedi, Paolo","Maggiore, Umberto"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233067","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15891","source":"PubMed","locations":["Italy","Wuhan","China","Dipartimento"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Case Report"],"weight":1,"_version_":1663352135328202753,"score":87.22917},{"pmid":32249089,"title":"Identification of Kidney Transplant Recipients with Coronavirus Disease 2019.","text":["Identification of Kidney Transplant Recipients with Coronavirus Disease 2019.","Coronavirus disease 2019 (COVID-19) is a novel and lethal infectious disease, posing a threat to global health security. The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available. To present the epidemiological, clinical, and therapeutic characteristics of KTx recipients infected with COVID-19, we report on a case series of five patients who were confirmed as having COVID-19 through nucleic acid testing (NAT) from January 1, 2020 to February 28, 2020. The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset. Four patients received a reduced dose of maintenance immunosuppressive therapy during hospitalization. As of March 4, 2020 NAT was negative for COVID-19 in three patients twice in succession, and their computed tomography scans showed improved images. Although greater patient numbers and long-term follow-up data are needed, our series demonstrates that mild COVID-19 infection in KTx recipients can be managed using symptomatic support therapy combined with adjusted maintenance immunosuppressive therapy.","Eur Urol","Zhang, Hui","Chen, Yan","Yuan, Quan","Xia, Qiu-Xiang","Zeng, Xian-Peng","Peng, Jing-Tao","Liu, Jing","Xiao, Xing-Yuan","Jiang, Guo-Song","Xiao, Han-Yu","Xie, Liang-Bo","Chen, Jing","Liu, Jia-Li","Xiao, Xiong","Su, Hua","Zhang, Chun","Zhang, Xiao-Ping","Yang, Hua","Li, Heng","Wang, Zhen-Di","32249089"],"abstract":["Coronavirus disease 2019 (COVID-19) is a novel and lethal infectious disease, posing a threat to global health security. The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available. To present the epidemiological, clinical, and therapeutic characteristics of KTx recipients infected with COVID-19, we report on a case series of five patients who were confirmed as having COVID-19 through nucleic acid testing (NAT) from January 1, 2020 to February 28, 2020. The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset. Four patients received a reduced dose of maintenance immunosuppressive therapy during hospitalization. As of March 4, 2020 NAT was negative for COVID-19 in three patients twice in succession, and their computed tomography scans showed improved images. Although greater patient numbers and long-term follow-up data are needed, our series demonstrates that mild COVID-19 infection in KTx recipients can be managed using symptomatic support therapy combined with adjusted maintenance immunosuppressive therapy."],"journal":"Eur Urol","authors":["Zhang, Hui","Chen, Yan","Yuan, Quan","Xia, Qiu-Xiang","Zeng, Xian-Peng","Peng, Jing-Tao","Liu, Jing","Xiao, Xing-Yuan","Jiang, Guo-Song","Xiao, Han-Yu","Xie, Liang-Bo","Chen, Jing","Liu, Jia-Li","Xiao, Xiong","Su, Hua","Zhang, Chun","Zhang, Xiao-Ping","Yang, Hua","Li, Heng","Wang, Zhen-Di"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249089","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.eururo.2020.03.030","keywords":["Clinical feature","Coronavirus disease 2019","Kidney transplant recipient"],"source":"PubMed","locations":["myalgia","fatigue"],"topics":["Case Report"],"weight":1,"e_drugs":["Creatinine","Nitrogen","Urea"],"_version_":1663352136235220994,"score":77.9595},{"pmid":32279418,"title":"Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).","text":["Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).","During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long-term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36-year-old kidney transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case-report. We stress the need for guidelines in transplant recipients with COVID-19 infection with particular regard to the management of therapy.","Transpl Infect Dis","Bartiromo, Marilu","Borchi, Beatrice","Botta, Annarita","Bagala, Alfredo","Lugli, Gianmarco","Tilli, Marta","Cavallo, Annalisa","Xhaferi, Brunilda","Cutruzzula, Roberta","Vaglio, Augusto","Bresci, Silvia","Larti, Aida","Bartoloni, Alessandro","Cirami, Calogero","32279418"],"abstract":["During the novel coronavirus pandemic, organ transplant recipients represent a frail susceptible category due to long-term immunosuppressive therapy. For this reason, clinical manifestations may differ from general population and different treatment approaches may be needed. We present the case of a 36-year-old kidney transplanted woman affected by Senior-Loken syndrome diagnosed with COVID-19 pneumonia after a contact with her positive mother. Initial symptoms were fatigue, dry cough and coryza; she never had fever nor oxygen supplementation. Hydroxychloroquine and lopinavir/ritonavir were started, and the antiviral drug was replaced with darunavir/cobicistat after two days for diarrhea. Immunosuppressant levels were closely monitored, and we observed very high tacrolimus trough levels despite initial dose reduction. The patient was left with steroid therapy alone. The peculiarity of clinical presentation and the management difficulties represent the flagship of our case-report. We stress the need for guidelines in transplant recipients with COVID-19 infection with particular regard to the management of therapy."],"journal":"Transpl Infect Dis","authors":["Bartiromo, Marilu","Borchi, Beatrice","Botta, Annarita","Bagala, Alfredo","Lugli, Gianmarco","Tilli, Marta","Cavallo, Annalisa","Xhaferi, Brunilda","Cutruzzula, Roberta","Vaglio, Augusto","Bresci, Silvia","Larti, Aida","Bartoloni, Alessandro","Cirami, Calogero"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279418","week":"202016|Apr 13 - Apr 19","doi":"10.1111/tid.13286","keywords":["COVID-19","drug-drug interaction","kidney transplant"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663890921989603328,"score":74.14717},{"pmid":32198834,"title":"Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?","text":["Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?","COVID-19 is novel infectious disease with an evolving understanding of its epidemiology and clinical manifestations. Immunocompromised patients often present atypical presentations of viral diseases. Herein we report a case of a COVID-19 infection in a solid organ transplant recipient, in which the first clinical symptoms were of gastrointestinal viral disease and fever, which further progressed to respiratory symptoms in 48h. In these high risk populations, protocols for screening for SARS-Cov2 may be needed to be re-evaluated.","Am J Transplant","Guillen, Elena","Pineiro, Gaston Julio","Revuelta, Ignacio","Rodriguez, Diana","Bodro, Marta","Moreno, Asuncion","Campistol, Josep M","Diekmann, Fritz","Ventura-Aguiar, Pedro","32198834"],"abstract":["COVID-19 is novel infectious disease with an evolving understanding of its epidemiology and clinical manifestations. Immunocompromised patients often present atypical presentations of viral diseases. Herein we report a case of a COVID-19 infection in a solid organ transplant recipient, in which the first clinical symptoms were of gastrointestinal viral disease and fever, which further progressed to respiratory symptoms in 48h. In these high risk populations, protocols for screening for SARS-Cov2 may be needed to be re-evaluated."],"journal":"Am J Transplant","authors":["Guillen, Elena","Pineiro, Gaston Julio","Revuelta, Ignacio","Rodriguez, Diana","Bodro, Marta","Moreno, Asuncion","Campistol, Josep M","Diekmann, Fritz","Ventura-Aguiar, Pedro"],"date":"2020-03-22T11:00:00Z","year":2020,"_id":"32198834","week":"202012|Mar 16 - Mar 22","doi":"10.1111/ajt.15874","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663352133588615169,"score":71.88956},{"pmid":32243690,"title":"A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.","text":["A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.","In December 2019, an outbreak of COVID-19 occurred in Wuhan, China, and spread to the whole of China and to multiple countries worldwide. Unlike SARS and MERS, where secondary transmission mostly occurred in hospital settings, COVID-19 transmission occurs in large numbers within families. Herein we report three cases of a familial cluster with one family member being a kidney transplant recipient. The initial clinical symptoms of COVID-19 in these three patients were the same, but their progression was different. Based on the severity of clinical symptoms, chest computer tomography findings and SARS-Cov-2 RNA test results, we admitted the husband to the respiratory intensive care unit (RICU) and used a treatment consisting of immunosuppressant reduction/cessation and low dose methylprednisolone-based therapy, and his wife to the respiratory isolation ward. In contrast, the son received in-home isolation and home-based care. All three family members made a full recovery.","Am J Transplant","Chen, Song","Yin, Qin","Shi, Huibo","Du, Dunfeng","Chang, Sheng","Ni, Li","Qiu, Haifang","Chen, Zhishui","Zhang, Jixian","Zhang, Weijie","32243690"],"abstract":["In December 2019, an outbreak of COVID-19 occurred in Wuhan, China, and spread to the whole of China and to multiple countries worldwide. Unlike SARS and MERS, where secondary transmission mostly occurred in hospital settings, COVID-19 transmission occurs in large numbers within families. Herein we report three cases of a familial cluster with one family member being a kidney transplant recipient. The initial clinical symptoms of COVID-19 in these three patients were the same, but their progression was different. Based on the severity of clinical symptoms, chest computer tomography findings and SARS-Cov-2 RNA test results, we admitted the husband to the respiratory intensive care unit (RICU) and used a treatment consisting of immunosuppressant reduction/cessation and low dose methylprednisolone-based therapy, and his wife to the respiratory isolation ward. In contrast, the son received in-home isolation and home-based care. All three family members made a full recovery."],"journal":"Am J Transplant","authors":["Chen, Song","Yin, Qin","Shi, Huibo","Du, Dunfeng","Chang, Sheng","Ni, Li","Qiu, Haifang","Chen, Zhishui","Zhang, Jixian","Zhang, Weijie"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243690","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15903","keywords":["COVID-19","kidney","novel coronavirus","pneumonia","transplantation","treatment"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"e_drugs":["Methylprednisolone"],"_version_":1663352135721418752,"score":68.45763}]}